| HBLTX | MNMWX | HBLTX / MNMWX | |
| Total Expense Ratio | 0.67 | 0.10 | 670% |
| Annual Report Gross Expense Ratio | 0.67 | 0.77 | 87% |
| Fund Existence | 16 years | 7 years | - |
| Gain YTD | 4.507 | 2.823 | 160% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11.1B | 260M | 4,269% |
| Annual Yield % from dividends | 3.36 | 3.64 | 92% |
| Returns for 1 year | 5.27 | 3.92 | 134% |
| Returns for 3 years | 19.57 | 19.23 | 102% |
| Returns for 5 years | 7.50 | 6.15 | 122% |
| Returns for 10 years | 41.05 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BITI | 25.96 | 0.67 | +2.65% |
| ProShares Shrt Bitcoin ETF | |||
| EAGG | 46.81 | -0.17 | -0.36% |
| iShares ESG U.S. Aggregate Bond ETF | |||
| AVSU | 87.69 | -0.75 | -0.85% |
| Avantis Responsible US Equity ETF | |||
| THNR | 25.64 | -0.29 | -1.11% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| EMOP | 49.52 | -1.64 | -3.20% |
| AB Emerging Markets Opportunities ETF | |||